Table 1

Bone mineralisation standard deviation scores in patients with cystic fibrosis

Male patientsFemale patients
⩽ 19 years (n = 32)> 19 years (n = 30)⩽ 19 years (n = 41)> 19 years (n = 31)
Height for age−0.77−1.15−0.97−0.74
(−3.24 to 0.94)(−3.23 to 0.81)(−2.52 to 1.49)(−2.18 to 1.69)
p < 0.001p < 0.001p < 0.001p = 0.003
Bone area for age−0.94−2.02−1.35−2.29
(−3.61 to 0.86)(−4.50 to −0.33)(−4.14 to 1.19)(−5.21 to 1.92)
p < 0.001p < 0.001p < 0.001p < 0.001
Bone area for height−0.42−0.481-150
(−2.93 to 1.28)(−2.86 to 1.39)
p = 0.018p = 0.004
BMC for bone area1.131-150 0.75
(−1.01 to 3.54)(−1.49 to 2.30)
p < 0.001p < 0.001
BMC for age−0.72−2.15−1.02−1.93
(−2.61 to 0.88)(−4.08 to 0.43)(−3.36 to 1.38)(−4.46 to 2.77)
p < 0.001p < 0.001p < 0.001p < 0.001
BMD for age0.05−1.80−0.37−1.56
(−1.94 to 1.82)(−4.21 to 1.22)(−3.24 to 1.47)(−3.40 to 2.61)
p = 0.822p < 0.001p = 0.05p < 0.001

  • Values are median (range).

  • p Values indicate whether SDSs are significantly different from zero.

  • ↵1-150 One boy had a bone area measurement and two girls had height measurements that were too small compared with the reference material to calculate the SDS.

  • BMC, bone mineral content; BMD, bone mineral density.